Senior communications executive with 10+ years’ experience developing multifaceted communication strategies within the Pharma/biotech space that reflect the company’s vision, values, and business direction. Track record of establishing trust and credibility at the executive level and being well-versed in championing consensus and approval for cross-functional communication efforts that support product launches, commercial activities, corporate narratives, internal messaging and brand advancement. Excel at optimizing communications platforms and processes and identifying new channels to maximize impact and engagement. Passion for building cultures that lead to ongoing excellence and business growth by attracting, developing, and retaining employees that feel empowered to push the boundaries of creativity, deliver groundbreaking innovation and are committed to living company values.• Product Launches: Developed and executed communications strategies and execution plans for three product launches – two in-line products ARISTADA® Two Month (1064mg) dose, ARISTADA INITIO®, and one novel product, LYBALVI® in four years• Marketing Strategy: Established the communications, PR, and marketing functions of 4 start-up companies in the life science and biotechnology industries to support strategic fundraising, partnering, and licensing initiatives; Results: successful sale of 2 companies (Bioflash and Tarpon Biosystems) and one IPO (Merrimack Pharmaceuticals)• Corporate Brand & Reputation: Conceived, implemented and managed strategic and tactical marketing communications solutions targeting a wide range of clients from global pharmaceutical companies to venture capitalists, to virtual start-ups resulting in a revenue increase of 50% in 2015 and a consistent YoY growth of >25% for 4 years• Product Communications: Led strategic branding, positioning, and successful launch of new service offering, advanceONE®, increasing revenue by 140% for quality/regulatory consulting services